| Literature DB >> 36014776 |
Humna Liaqat1, Amna Parveen2, Sun Yeou Kim2.
Abstract
L-tryptophan (Trp) contributes to regulating bilateral communication of the gut-brain axis. It undergoes three major metabolic pathways, which lead to formation of kynurenine, serotonin (5-HT), and indole derivatives (under the control of the microbiota). Metabolites from the principal Trp pathway, kynurenic acid and quinolinic acid, exhibit neuroprotective activity, while picolinic acid exhibits antioxidant activity, and 5-HT modulates appetite, sleep cycle, and pain. Abnormality in Trp plays crucial roles in diseases, including depression, colitis, ulcer, and gut microbiota-related dysfunctions. To address these diseases, the use of natural products could be a favorable alternative because they are a rich source of compounds that can modulate the activity of Trp and combat various diseases through modulating different signaling pathways, including the gut microbiota, kynurenine pathway, and serotonin pathway. Alterations in the signaling cascade pathways via different phytochemicals may help us explore the deep relationships of the gut-brain axis to study neuroprotection. This review highlights the roles of natural products and their metabolites targeting Trp in different diseases. Additionally, the role of Trp metabolites in the regulation of neuroprotective and gastroprotective activities is discussed. This study compiles the literature on novel, potent neuroprotective agents and their action mechanisms in the gut-brain axis and proposes prospective future studies to identify more pharmaceuticals based on signaling pathways targeting Trp.Entities:
Keywords: 5-HT; L-tryptophan; gastroprotective; gut–brain axis; metabolites; neuroprotective; phytochemicals; signaling pathways
Mesh:
Substances:
Year: 2022 PMID: 36014776 PMCID: PMC9413544 DOI: 10.3390/nu14163270
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1Three Integrated pathways of tryptophan metabolism. Tryptophan (Trp) is an essential amino acid obtained from dietary protein. The majority of Trp is metabolized alongside the kynurenine pathway to produce different molecules collectively referred to as kynurenines. The most widely studied fate of Trp is the downstream conversion to serotonin and melatonin. Trp availability is also altered by gut microbes generating either indole or its derivatives, tryptamine or serotonin, which can affect the gastrointestinal tract. TDO, tryptophan 2,3-dioxygenase; IDO, indoleamine 2,3-dioxygenase; Fmd, formamidase; KAT, kynurenine aminotransferase; KrA, kynureninase A; KMO, kynurenine hydroxylase (monooxygenase); KrB, kynureninase B; NAD, nicotinamide adenine dinucleotides; TpH, tryptophan hydroxylase; AAAD, aromatic amine acid decarboxylase; AANAT, arylakylamine-N-acetyltransferase; HIOMT, hydroxyindolo-O-methyltransferase; MAO, monoamine oxidase; AlDh, aldehyde dehydrogenase; TrpD, tryptophan decarboxylase; TNA, tryptophanase; SLT, sulfotransferase; TMO, tryptophan monooxygenase; IaaH, indoleacetamide hydrolase; IaaD, indoleacetate decarboxylase; Arat, aromatic amino acid aminotransferase; ID, indolepyruvate decarboxylase; ADhn, alcohol dehydrogenase; fldH, phenyllactate dehydrogenase; ILD, indolelactate dehydratase; ACD, acyl-CoA dehydrogenase.
Figure 2GBA targeting tryptophan: Peripheral serotonin synthesis by enterochromaffin cells is stimulated by gut microbiota. 5-HT from the gut has various direct or indirect effects, such as gut motility and gut microbiota. This affects central serotoninergic pathways by moderating Trp and tryptamine availability. Gut microbiota affect the kynurenine pathway, which plays a critical role in inflammatory mechanisms and neuroendocrine functions. Dietary Trp can also be directly converted by the gut microbiota into AhR ligands and can help to perform many functions. Trp; tryptophan; Kyn, kynurenine; KynA, kynurenic acid; quinolinic acid; 3HANA, 3-hydroxyanthranilic acid; 3-HK, 3-hydroxykynurenine; 5-HTP, 5-hydroxytryptophan, 5-HT, 5-hydroxytryptamine; 5-HIAA, 5-hydroxyindole acetic acid; AhR, aryl hydrocarbon receptor; EC, enterochromaffin cells.
Natural products and the derived potential compounds that exhibit gastroprotective and neuroprotective effects through regulating the GBA targeting tryptophan.
| Compound | Origin | Targeted Pathway | Family | Class | Pharmacological Target | Pharmacological Action | References |
|---|---|---|---|---|---|---|---|
| Anonaine |
| Monoaminergic |
| Alkaloid | 5-HT | Antidepressant, | [ |
| Anthocyanins |
| Microbial, kynurenine, MAO |
| Flavonoid | BNDF, 5-HT, gut | Anti-neuroinflammatory, | [ |
| Asiaticoside |
| Kynurenine, microbial |
| Terpenoid | BDNF, QnA, inflammatory markers, microbiota homeostasis, and mucosal barrier | Prevents neurotoxicity, lipid peroxidation, neuroinflammation; improves colitis, GI motility, and homeostasis | [ |
| Astragaloside IV |
| BDNF, kynurenine |
| Polyphenol | 5-HT, dopamine, and MAO levels; oxidative, apoptotic, and inflammatory parameters | Neuroprotection against toxicity, inflammation, oxidative stress, apoptosis, and depression | [ |
| Bacoside A |
| Serotonergic system |
| Terpenoid | BDNF, 5-HT receptors, and synaptic proteins | Antidepressant and anti-anxiolytic | [ |
| Carvacrol |
| Serotoninergic, kynurenine |
| Phenol | 5-HT and BDNF | Gastroprotective and provides neuroprotection against memory degeneration, inflammation, oxidative stress, and depression | [ |
| Catechins |
| Microbial, kynurenine |
| Flavonoid | QnA, BDNF, microbes, and MAO | Neuroprotection against anxiety, oxidative stress, and neurotoxicity | [ |
| Chrysin |
| Kynurenine, serotoninergic, and microbial |
| Flavonoid | MAO and 5-HT | Gut and neuroprotection against oxidative stress, apoptosis, and inflammation | [ |
| Curcumin |
| Kynurenic, serotoninergic |
| Phenol | 5-HT, kynurenine, QnA, BDNF | Neuroprotection against oxidative stress, apoptosis, and depression | [ |
| Ellagic acid |
| Kynurenine, serotoninergic |
| Phenol | 5-HT and BDNF | Neuroprotection against inflammation, oxidative stress, and depression; improves memory | [ |
| Eugenol |
| Monoaminergic, kynurenine |
| Phenol | Neuroprotection against toxicity, oxidative stress, and IBS-induced stress | [ | |
| Ferulic acid |
| Serotoninergic, microbial |
| Phenol | 5-HT, MAOA, and BDNF | Elevates 5-HT levels and has antidepressant and anti-neurotoxic effects | [ |
| Ginkgolides B |
| Serotonergic, microbial |
| Terpenoid | BNDF and 5-HT | Reduces depression and anxiety and improves cognitive abilities | [ |
| Ginsenoside Rg5 |
| Serotonergic, dopaminergic, GABAergic system |
| Terpenoid | BNDF and 5-HT | Antidepressant | [ |
| Hesperidin |
| Serotonergic, kynurenine, microbial |
| Flavonoid | BDNF | Regulates GI motility and provides neuroprotection against toxicity, inflammation, and depression | [ |
| Hyperforin |
| MAOA, serotonergic system |
| Terpenoid | 5-HT, MAOA, and the kynurenine/Trp ratio | Antidepressant | [ |
| Limonene |
| Kynurenine, serotonergic, microbial |
| Terpene | Melatonin, BDNF, and gut microbiome | Neuroprotection against inflammation and oxidative stress (IBD) | [ |
| Linalool |
| Serotonergic system, microbial |
| Terpenoid | 5-HT, gut microbiota, inflammatory markers, and mucosal immunity | Neuroprotection against inflammation, oxidative stress, and neural death; improves gut microbiota homeostasis and cognitive health | [ |
| Luteolin |
| Monoaminergic, serotonergic |
| Flavonoid | MAO neurotransmitters, 5-HT-related receptors, BDNF, 5-HT, and monoamine transporter | Antidepressant-like effect, inhibits serotonin reuptake, and promotes lipolysis and fatty acid β-oxidation | [ |
| Lycopene |
| BDNF, kynurenine |
| Carotenoid | BDNF, serotonin, dopamine, inflammatory, and oxidative markers | Neuroprotection against inflammation, oxidative stress, toxicity, and stress | [ |
| Naringin |
| Kynurenine |
| Flavonoid | Neuroinflammatory, apoptotic, and oxidative markers | Neuroprotection against inflammation, oxidative stress, toxicity, and stress | [ |
| Oleanolic acid |
| Monoaminergic, serotonergic system |
| Terpenoid | 5-HT and MAOA | Anxiolytic, antidepressant | [ |
| Oleuropein |
| Dopaminergic, microbial system |
| Phenol | Inflammatory markers, gut microbiota, and 5-HT | Neuroprotection against inflammation, improvement of the gut microbiota homeostasis and cognitive health | [ |
| Omega-3 fatty acids | Fish oil | Kynurenine or serotonergic | Fatty acid | BDNF, serotonin, and IDO | Antidepressant and anti-anxiolytic; improves memory | [ | |
| Piperine |
| Monoaminergic, serotonergic, BDNF |
| Alkaloid | 5-HT and MAOA | Neuroprotection against inflammation, oxidative stress, toxicity, and stress | [ |
| Proanthocyanidins |
| Serotonergic |
| Polyphenol | 5-HT | Antidepressant | [ |
| Resveratrol |
| Serotoninergic |
| Polyphenol | 5-HT, SERT, and BDNF | Enhances 5-HT levels, inhibits 5-HT reuptake, provides neuroprotection against toxicity, oxidative damage, and IBS-like effect | [ |
| Rutin |
| Kynurenine, serotonergic |
| Flavonoid | NMDA, BDNF, QnA, oxidative, apoptotic, and inflammatory parameters | Neuroprotection against inflammation, oxidative stress, apoptosis, toxicity, and depression | [ |
| Salidroside |
| Microbial, kynurenine |
| Glycoside | Inflammatory markers, gut microbiota, and 5-HT | Antidepressant, regulates gut–brain axis by modulation of gut microbiota and inflammation | [ |
| Sanggenon G |
| Serotonergic |
| Flavonoid | BNDF | Antidepressant, antistress agent, memory-enhancing agent | [ |
| Theanine |
| BDNF |
| Amino acid | 5-HT, BDNF, and dopamine | Antidepressant | [ |
| Tryptophan | Human breast milk | Kynurenine, microbial | Amino acid | AhR | Improves the sleep cycle and reduces infantile colic | [ | |
| Tryptophan |
| Microbial |
| Amino acid | 5-HT and gut microbiota | Neuroprotective and improves cognition | [ |
| Tryptophan |
| Microbial, serotonergic |
| Amino acid | SSRI, 5-HT, and EC cell count | Anxiolytic, antidepressant, and protects against ulcers | [ |
| Tryptophan |
| Serotonergic system |
| Amino acid | 5-HT | Antidepressant, 5-HT reuptake inhibitor, and 5-HT metabolism activator | [ |
| 2- |
| Serotonergic, microbial, kynurenine |
| Vitamin | Proinflammatory cytokines, 5-HT, and antioxidative markers | Reduces depression and anxiety and stabilizes the gut microbiota | [ |
|
| Serotonergic, dopaminergic |
| 5-HT receptor | Antidepressant, memory enhancer, and regulates neuroactive ligand–receptor interaction | [ | ||
|
| Kynurenine, serotonergic, microbial |
| BDNF, gut microbiome, and serotonin | Antidepressant, anxiolytic, and mediates the gut microbiota | [ | ||
|
| Kynurenine, serotonergic, microbial system |
| BNDF, 5-HT, oxidative markers, and gut microbiota | Protects against neurotoxicity, improves depression, memory, behavioral activities, and the gut microbiota | [ | ||
|
| Serotonergic system |
| 5-HT | Antidepressant, modulates 5-HT reuptake/release | [ | ||
| Tualang honey | Microbial, BDNF | Memory restoration and improvement in depression and cognitive and neural stresses | [ |
Figure 3Structures of bioactive metabolites from natural products: Tryptophan—human breast milk, Moringa oleifera, and Nelumbo nucifera; theanine—Camellia sinensis; anonaine—Annona muricata; piperine—Piper nigrum; lycopene—Citrullus lanatus; 2-O-β-d-glucopyranosyl-l-ascorbic acid—Lycium barbarum.
Figure 4Structures of bioactive metabolites from natural products: Anthocyanin—Rubus fruticosus; Catechin—Rhizophora mucronata; Chrysin—Matricaria chamomilla; Curcumin—Curcuma longa; Ellagic acid—Punica granatum; Eugenol—Syzygium aromaticum; Ferulic acid—Ferula foetida; Hesperidin—Citrus limon; Oleuropein—Olea europaea.
Figure 5Structures of bioactive metabolites from natural products: Proanthocyanin—Cinnamomum zeylanicum; Rutin—Fagopyrum esculentum; Sanggenon G—Morus alba; Salidroside—Rhodiola rosea; Resveratrol—Polygonum cuspidatum; Astragaloside IV—Astragalus membranaceus; Carvacrol—Origanum vulgare; Limonene—Citrus sinensis.
Figure 6Structures of bioactive metabolites from natural products: Asiaticoside—Centella asiatica; Bacoside—Bacopa monnieri; Ginkgolides B—Ginkgo biloba; Linalool—Lavandula angustifolia; Ginsenoside Rg5—Panax ginseng; Oleanolic acid—Pimenta pseudocaryophyllus; Hyperforin—Hypericum perforatum.
Figure 7Metabolism of Trp by natural products and constituents via different signaling pathways: Trp is metabolized via the kynurenine pathway (95%), serotonin pathway (1%), and microbial pathway (3%). 1: anonaine, 2: anthocyanin, 3: asiaticoside, 4: astragaloside IV, 5: bacoside A, 6: carvacrol, 7: catechin, 8: chrysin, 9: curcumin, 10: ellagic acid, 11: eugenol, 12: ferulic acid, 13: ginkgolides B, 14: ginsenoside Rg5, 15: hesperidin, 16: hyperforin, 17: limonene, 18: linalool, 19: luteolin, 20: lycopene, 21: naringin, 22: oleanolic acid, 23: oleuropein, 24: omega-3 fatty acids, 25: piperine, 26: proanthocyanidins, 27: resveratrol, 28: rutin, 29: salidroside, 30: sanggenon G, 31: theanine, 32–35: tryptophan, 36: 2-O-β-d-glucopyranosyl-l-ascorbic acid, 37: Mimosa pudica, 38: Poria cocos, 39: Salvia officinalis, 40: Tagetes lucida, 41: Tualang honey.
Figure 8Natural products with neuroprotective and gastroprotective effects on the regulation of the GBA targeting tryptophan and its metabolites through different pathways: Specific natural products and the derived compounds exhibit specific functions in the bidirectional communication of the gut and brain. 1: anonaine, 2: anthocyanin, 3: asiaticoside, 4: astragaloside IV, 5: bacoside A, 6: carvacrol, 7: catechin, 8: chrysin, 9: curcumin, 10: ellagic acid, 11: eugenol, 12: ferulic acid, 13: ginkgolides B, 14: ginsenoside Rg5, 15: hesperidin, 16: hyperforin, 17: limonene, 18: linalool, 19: luteolin, 20: lycopene, 21: naringin, 22: oleanolic acid, 23: oleuropein, 24: omega-3 fatty acids, 25: piperine, 26: proanthocyanidins, 27: resveratrol, 28: rutin, 29: salidroside, 30: sanggenon G, 31: theanine, 32–35: tryptophan, 36: 2-O-β-d-glucopyranosyl-l-ascorbic acid, 37: Mimosa pudica, 38: Poria cocos, 39: Salvia officinalis, 40: Tagetes lucida, 41: Tualang honey.